Haydon RC - Search Results

1

The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells.

Chen X, Luther G, Zhang W, Nan G, Wagner ER, Liao Z, Wu N, Zhang H, Wang N, Wen S, He Y, Deng F, Zhang J, Wu D, Zhang B, Haydon RC, Zhou L, Luu HH, He TC. Chen X, et al. Among authors: haydon rc. Cell Physiol Biochem. 2013;32(4):1083-96. doi: 10.1159/000354508. Epub 2013 Nov 4. Cell Physiol Biochem. 2013. PMID: 24217649 Free article.

2

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, Jiang W, Ishikawa A, Peabody T, Montag A, Simon MA, He TC. Haydon RC, et al. Clin Cancer Res. 2002 May;8(5):1288-94. Clin Cancer Res. 2002. PMID: 12006550 Free PMC article.

3

Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.

Wang HL, Wang J, Xiao SY, Haydon R, Stoiber D, He TC, Bissonnette M, Hart J. Wang HL, et al. Int J Cancer. 2002 Oct 1;101(4):301-10. doi: 10.1002/ijc.10630. Int J Cancer. 2002. PMID: 12209953

4

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, Peabody T, Simon MA, Montag AG, He TC. Haydon RC, et al. Int J Cancer. 2002 Dec 1;102(4):338-42. doi: 10.1002/ijc.10719. Int J Cancer. 2002. PMID: 12402302 Free PMC article.

5

Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.

Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, Zhou L, Breyer B, Feng T, Gupta P, He TC, Phillips FM. Paul R, et al. Among authors: haydon rc. Spine (Phila Pa 1976). 2003 Apr 15;28(8):755-63. Spine (Phila Pa 1976). 2003. PMID: 12698117 Free PMC article.

6

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.

Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, Jiang W, Luu HH, Vanichakarn P, Szatkowski JP, Park JY, Breyer B, He TC. Zhou L, et al. Among authors: haydon rc. Cancer Lett. 2003 Apr 25;193(2):161-70. doi: 10.1016/s0304-3835(03)00013-2. Cancer Lett. 2003. PMID: 12706873 Free PMC article.

7

Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. Cheng H, et al. Among authors: haydon rc. J Bone Joint Surg Am. 2003 Aug;85(8):1544-52. doi: 10.2106/00004623-200308000-00017. J Bone Joint Surg Am. 2003. PMID: 12925636

8

Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.

Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC. Peng Y, et al. Among authors: haydon rc. J Cell Biochem. 2003 Dec 15;90(6):1149-65. doi: 10.1002/jcb.10744. J Cell Biochem. 2003. PMID: 14635189

9

Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy.

Haydon RC, Zhou L, He TC. Haydon RC, et al. Cancer Biol Ther. 2004 Apr;3(4):393-4. doi: 10.4161/cbt.3.4.756. Epub 2004 Apr 12. Cancer Biol Ther. 2004. PMID: 15004535 Free article. No abstract available.

10

Dual regulation of gene expression mediated by tetracycline and Cre recombinase.

Park JY, Luo Q, Jiang W, Kang Q, Peng Y, Strom C, Luu HH, Haydon RC, He TC. Park JY, et al. Among authors: haydon rc. Biotechniques. 2004 Mar;36(3):390-2, 394, 396. doi: 10.2144/04363BM03. Biotechniques. 2004. PMID: 15038152 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters